[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370478-105":59,"doc-detail-370478-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","anthracyclines-induced-vascular-endothelial-dysfunction-in-cancer-patients-and-survivors-using-brachial-flow-mediated-dilation-fmd-tool-a-systematic-review-and-meta-analysis","Anthracyclines‑Induced Vascular Endothelial Dysfunction in Cancer Patients and Survivors Using Brachial Flow‑Mediated Dilation (FMD) Tool - A Systematic Review and Meta-Analysis","","Anthracyclines are effective antineoplastic drugs, yet their use is limited by dose-dependent cardiotoxicity. Vascular endothelial dysfunction is an early, independent event in cardiovascular disease and may precede anthracycline-induced cardiotoxicity. This review evaluates evidence for anthracycline-induced vascular endothelial dysfunction in cancer patients and survivors using brachial flow-mediated dilation (FMD), comparing treated groups with healthy controls or baseline through systematic search and random-effects meta-analysis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/anthracyclines-induced-vascular-endothelial-dysfunction-in-cancer-patients-and-survivors-using-brachial-flow-mediated-dilation-fmd-tool-a-systematic-review-and-meta-analysis/370478/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/anthracyclines-induced-vascular-endothelial-dysfunction-in-cancer-patients-and-survivors-using-brachial-flow-mediated-dilation-fmd-tool-a-systematic-review-and-meta-analysis/370478.png","ImageObject",300,407,{"name":92,"@type":93},"Jake","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is vascular endothelial dysfunction important in anthracycline cardiotoxicity?","Question",{"text":112,"@type":113},"It is an early, independent event that may precede the clinical onset of anthracycline-induced cardiotoxicity, making it a valuable target for early detection.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was FMD used to assess endothelial function in the included studies?",{"text":117,"@type":113},"FMD is a non-invasive ultrasound-based technique that measures brachial artery endothelium-dependent vasodilation after induced ischemia, typically using a forearm cuff.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the meta-analysis find about FMD differences between anthracycline-treated patients and controls?",{"text":121,"@type":113},"Overall, anthracycline-treated patients showed a significant reduction in FMD versus healthy controls, while changes toward decline from baseline were not significant; childhood cancer subgroups showed consistent significant reductions.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370478,1790563583,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084928904,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Cardiovascular Toxicology (2025) 25:692–718  \n[https://doi.org/10.1007/s12012-025-09986-2](https://doi.org/10.1007/s12012-025-09986-2)  \nAnthracyclines‑Induced Vascular Endothelial Dysfunction in Cancer Patients and Survivors Using Brachial Flow‑Mediated Dilation (FMD) Tool: A Systematic Review and Meta‑Analysis  \nLana A. Kattan1 · Sara M. Abulola1 · Mohamed Izham Mohamed Ibrahim2 · Zaid H. Maayah1  \nReceived: 5 December 2024 / Accepted: 19 March 2025 / Published online: 3 April 2025 © The Author(s) 2025  \nAbstract  \nAnthracyclines are effective antineoplastic drugs; however, their use is constrained by dose-dependent cardiotoxicity. Vascular endothelial dysfunction is an early independent event in cardiovascular diseases and may precede anthracycline-induced cardiotoxicity. Brachial flow-mediated dilation (FMD) is a non-invasive technique for evaluating vascular endothelial function. We evaluated the evidence on anthracycline-induced vascular endothelial dysfunction in cancer patients and survivors using FMD. Studies measuring FMD in anthracycline-treated active cancer patients or survivors were retrieved from inception to August 2024 using PubMed, Embase, and Scopus. The primary outcome was the difference in FMD between anthracycline-treated patients and healthy controls or baseline. We performed the meta-analysis using a random-effects model and evaluated the certainty in effect estimates. Overall, 18 studies (n = 841 patients) met the inclusion criteria. Compared to the baseline, a non-significant change toward a decline in FMD was observed. However, a significant reduction in FMD was observed in anthracycline-treated patients compared to healthy controls (standardized mean difference (SMD): − 0.6082; 95%  \nCI: − 0.8963 to − 0.3201; p \u003C 0.0001) . Subgroup analyses revealed consistent significant reductions in FMD for childhood cancers (SMD: − 0.7189; 95% CI: − 0.9903 to − 0.4476; p \u003C 0.0001), while adult cancers showed no significant difference. No significant publication bias was detected overall for healthy control comparisons. High heterogeneity was observed in the included studies (I2 = 81.7808% versus healthy controls and I2 = 75.6876% for childhood cancers subgroup analysis) . Anthracyclines induce vascular endothelial dysfunction, indicated by lower FMD in cancer patients and survivors, particularly among those with childhood cancers, who might be at risk of long-term cardiovascular complications.  \nKeywords Anthracycline · Endothelial dysfunction · Flow-mediated dilation (FMD) · Childhood cancers  \nIntroduction  \nAnthracyclines are effective chemotherapies against various malignancies, including breast cancer, lymphomas, and leukemias [1] . However, their clinical utility is limited by dose-dependent cardiotoxicity [1, 2] . Due to advancements in cancer diagnosis and treatment, cancer mortality rates are declining [3] . In long-term survivors, however,  \n* Zaid H. Maayah [almaayah@qu.edu.qa](almaayah@qu.edu.qa)  \n1 Department of Pharmaceutical Sciences, College of Pharmacy, QU Health, Qatar University, 2713 Doha, Qatar  \n2 Clinical Pharmacy and Practice Department, College of Pharmacy, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar  \ncardiovascular complications remain the primary cause of non-cancer-related morbidity and mortality [4] . Compared to the general population, cancer survivors have an eightfold increased risk of cardiovascular-related mortality, which may persist up to 45 years after treatment [4] . Childhood cancer survivors, in particular, often experience a long latency period between their anthracycline treatment and the onset of clinical cardiac dysfunction [5] . Thus, early detection of anthracycline-induced cardiotoxicity can help initiate treatment that protects these populations later in life.  \nFlow-mediated dilation (FMD), also known as brachial artery reactivity (BAR), is a non-invasive technique for assessing endothelial function by evaluating the peripheral brachial artery endoth","cbCaieHMTb2Z5eYx","https://ap.wps.com/l/cbCaieHMTb2Z5eYx","pdf",2821787,27,"English","# Abstract\n# Introduction\n# Methods\n## Search Strategy","[{\"question\":\"Why is vascular endothelial dysfunction important in anthracycline cardiotoxicity?\",\"answer\":\"It is an early, independent event that may precede the clinical onset of anthracycline-induced cardiotoxicity, making it a valuable target for early detection.\"},{\"question\":\"How was FMD used to assess endothelial function in the included studies?\",\"answer\":\"FMD is a non-invasive ultrasound-based technique that measures brachial artery endothelium-dependent vasodilation after induced ischemia, typically using a forearm cuff.\"},{\"question\":\"What did the meta-analysis find about FMD differences between anthracycline-treated patients and controls?\",\"answer\":\"Overall, anthracycline-treated patients showed a significant reduction in FMD versus healthy controls, while changes toward decline from baseline were not significant; childhood cancer subgroups showed consistent significant reductions.\"}]","Anthracyclines‑Induced Vascular Endothelial Dysfunction in Cancer Patients and Survivors Using Brachial Flow‑Mediated Dilation (FMD) Tool - A Systematic Review and Meta-Analysis | PDF",1790188734,68,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8115a8cb3679b5aeb85a4c0ffe314c11.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/42b29d7c35925267e625afee1a83a506.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fd17a6cca2095503c52eb797c8b05fd9.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4bd0f8ea83d205b2be03f9cc5b1535a8.webp",980,1301]